
Researchers from ICO Girona-IDIBGI participate in the study of a new treatment that improves the survival of advanced ovarian cancer patients
An international study that has just been published in the scientific journal The New England Journal of Medicine has shown that the administration of niraparib after conventional chemotherapy in patients with newly diagnosed advanced ovarian cancer improves their progression-free survival and reduces the risk of …